New evidence for medical cannabis
A NEW focus of this year’s MardiGrass is the issue of medicinal cannabis that has featured prominently in the press this year.
Throughout the year the Nimbin Hemp Embassy has embraced local dispenser Tony Bower from Mullaway Medical Cannabis whose clients include sufferers of multiple sclerosis, HIV, cancer and chronic pain.
In line with growing documented evidence, Tony’s clients have reported great relief from various ailments without the side effects of pharmaceutical pain killers and treatments they were previously using.
Hemp has also been successfully used as a treatment for nausea, spasticity, glaucoma, epilepsy, and as an analgesic and tranquiliser.
The cannabinoids contained in marijuana have proven analgesic and antibiotic properties and can be used to treat sore muscles, arthritic pain, burns, and many skin ailments.
The keynote speaker at this year’s MardiGrass is Dr Bob Melamede from Colorado in the United States.
“Australia has its roots in the struggle for freedom – a perfect place to seed the cannabis revolution,” he said.
‘Dr Bob’ as he is affectionately known, has a PhD in molecular biology and biochemistry from the City University of New York and is currently president and CEO of Cannabis Science Inc, a company that works with world authorities targeting chronic illnesses with cannabis.
He retired as chairman of the Biology Department at University of Colorado, Colorado Springs in 2005, where he still teaches.
He is a recognised expert on the biology of the cannabis plant, how it relates to the human endocannabinoid system, and why the plant has the potential to treat a range of diseases and illnesses.
He will speak on the anti-aging and anti-cancer properties of cannabis.
“We at Cannabis Science are trying to make cannabis extracts available in every state in the United States, and to have the government health care programs pay for them,” he said.
“It is clear that many war veterans are already using herbal cannabis to relieve the symptoms of post traumatic stress disorder.
“Consequently there is a clear need for standardised, approved oral cannabis products which can be provided to veterans and others who can benefit from its use.”